News & Opinion
Top 10 Innovations
Cell & Molecular Biology
Disease & Medicine
Ecology & Environment
Genetics & Genomics
Pharma & Biotech
Image of the Day
Clinical Trial Database Launches
Bob Grant | Oct 12, 2016
OpenTrials.net seeks to increase transparency and make clinical research more accessible to the public.
Pet Meds Adapted from Human Therapies
Jenny Rood | Oct 1, 2016
Companies focused on developing treatments for dogs, cats, and horses are bringing a diverse array of products to the pet medicine market.
Feds Demand More Clinical Trial Reporting
Kerry Grens | Sep 19, 2016
Expanded US Health and Human Services rules will require the results of more human studies to be made public.
The Challenges of Rare-Disease Research
Jyoti Madhusoodanan | Sep 1, 2016
With few resources and hesitant investors, basic scientists must rely on clinicians, patient advocates, and their own keen eye for biological connections.
Immunotherapy for Alzheimer’s Disease Shows Promise
Alison F. Takemura | Aug 31, 2016
Biogen’s aducanumab reduces amyloid-β plaques in a dose-dependent manner, according to interim results of a Phase 1b clinical trial.
CRISPR Therapy to Enter Trials
Jef Akst | Jul 25, 2016
Researchers in China will use the CRISPR-Cas9 system to edit T cells extracted from patients with cancer before those cells are returned to the body to target malignant ones.
Cancer Immunotherapy Trial Suspended After Deaths
Kerry Grens | Jul 8, 2016
Juno Therapeutics asks the US Food and Drug Administration for permission to restart the CAR-T experiments without chemotherapy.
Composite Endpoints in Clinical Trials
Sarah C.P. Williams | Jul 1, 2016
There’s a right way and a wrong way to boost the statistical sensitivity of this type of clinical studies.
Vaccines Protect Mice Against Zika Infection
Alison F. Takemura | Jun 29, 2016
Two different vaccines confer complete immunity for two months, researchers report.
NYU Halts Studies, Suspends Investigator
Bob Grant | Jun 28, 2016
Experiments conducted at the New York University School of Medicine violated several research standards, according to US Food and Drug Administration investigators.